Signant Health is a company focused on evidence generation for the life sciences sector. It provides technology and services to help pharmaceutical and biotechnology organizations digitally enable their clinical trials and produce high-quality data. Founded in 2018, the company operates across more than 90 countries and has contributed to hundreds of new drug approvals, supporting an estimated 25% of novel drug approvals across the FDA and EMA between 2021 and 2024.
The company's technical work centers on its SmartSignals ecosystem, a suite of eClinical solutions designed to modernize clinical trials. This includes software for Electronic Data Capture (EDC), electronic Clinical Outcome Assessment (eCOA), Randomization and Trial Supply Management (RTSM), and eConsent. Additional products cover patient engagement applications, telemedicine solutions, and clinical supply chain management software.
Roles at Signant Health involve developing and maintaining these clinical trial software platforms within the digital health domain. The technology stack supports the collection and management of electronic data from clinical sites and patients worldwide, a critical function for advancing new therapies through regulatory approval.
